BE621842A - - Google Patents

Info

Publication number
BE621842A
BE621842A BE621842DA BE621842A BE 621842 A BE621842 A BE 621842A BE 621842D A BE621842D A BE 621842DA BE 621842 A BE621842 A BE 621842A
Authority
BE
Grant status
Grant
Patent type
Prior art keywords
gt
lt
emi id
emi
id
Prior art date
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

Links

Claims (1)

  1. <EMI ID=1.1> <EMI ID = 1.1>
    <EMI ID=2.1> <EMI ID = 2.1>
    Page 7, ligne 25, Page 7, line 25,
    <EMI ID=3.1> <EMI ID=4.1> <EMI ID = 3.1> <EMI ID = 4.1>
    <EMI ID=5.1> <EMI ID = 5.1>
    Nous vous prions de bien vouloir faire Annexer la présente lettre rectificative au dossier de la demande de brevet We ask you to make Attach this letter of amendment in the file of the patent application
    <EMI ID=6.1> <EMI ID = 6.1>
BE621842A 1962-08-27 BE621842A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR907900A FR1339628A (en) 1962-08-27 1962-08-27 Method for producing new 1, 2, 4-triazolones- (5)

Publications (1)

Publication Number Publication Date
BE621842A true BE621842A (en)

Family

ID=8785801

Family Applications (1)

Application Number Title Priority Date Filing Date
BE621842A BE621842A (en) 1962-08-27

Country Status (2)

Country Link
BE (1) BE621842A (en)
FR (2) FR1339628A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273309A2 (en) * 1986-12-19 1988-07-06 Merrell Dow Pharmaceuticals Inc. 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
EP0273310A2 (en) * 1986-12-19 1988-07-06 Merrell Pharmaceuticals Inc. 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
US4946856A (en) * 1986-12-19 1990-08-07 Merrell Dow Pharmaceuticals Inc. 5-phenyl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
US5087634A (en) * 1990-10-31 1992-02-11 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5140036A (en) * 1990-09-19 1992-08-18 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5229406A (en) * 1990-09-19 1993-07-20 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5238952A (en) * 1990-10-31 1993-08-24 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5436252A (en) * 1986-12-19 1995-07-25 Merrell Dow Pharmaceuticals Inc. 5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
US5451592A (en) * 1991-04-05 1995-09-19 C.D. Searle & Co. Method of using N-arylheteroarylalkyl 1-heteroaryl-imidazol-2-one compounds for treatment of a glaucoma disorder

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436252A (en) * 1986-12-19 1995-07-25 Merrell Dow Pharmaceuticals Inc. 5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
EP0273310A2 (en) * 1986-12-19 1988-07-06 Merrell Pharmaceuticals Inc. 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
US4946856A (en) * 1986-12-19 1990-08-07 Merrell Dow Pharmaceuticals Inc. 5-phenyl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0273309A3 (en) * 1986-12-19 1991-01-09 Merrell Dow Pharmaceuticals Inc. 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
EP0273310A3 (en) * 1986-12-19 1991-01-09 Merrell Pharmaceuticals Inc. 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0273309A2 (en) * 1986-12-19 1988-07-06 Merrell Dow Pharmaceuticals Inc. 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
US5229406A (en) * 1990-09-19 1993-07-20 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5140036A (en) * 1990-09-19 1992-08-18 G. D. Searle & Co. 1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5238952A (en) * 1990-10-31 1993-08-24 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5087634A (en) * 1990-10-31 1992-02-11 G. D. Searle & Co. N-substituted imidazol-2-one compounds for treatment of circulatory disorders
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
US5451591A (en) * 1991-03-21 1995-09-19 G. D. Searle & Co. Method of using 5-arylheteroarylalkyl-1,3 5-trisubstituted-1,24-triazole compounds for treatment of circulatory disorders
US5451592A (en) * 1991-04-05 1995-09-19 C.D. Searle & Co. Method of using N-arylheteroarylalkyl 1-heteroaryl-imidazol-2-one compounds for treatment of a glaucoma disorder

Also Published As

Publication number Publication date Type
FR2669M (en) grant
FR1339628A (en) 1963-10-11 grant

Similar Documents

Publication Publication Date Title
BE621842A (en)
BE626730A (en)
BE623301A (en)
BE621473A (en)
BE625403A (en)
BE625446A (en)
BE615804A (en)
BE626776A (en)
BE621996A (en)
BE626824A (en)
BE622379A (en)
BE626747A (en)
BE626072A (en)
BE622760A (en)
BE622195A (en)
BE620869A (en)
BE621433A (en)
BE625591A (en)
BE621200A (en)
BE626839A (en)
BE617648A (en)
BE621602A (en)
BE623295A (en)
BE624579A (en)
BE623937A (en)